FORBES ARTICLE makes strong case for "CO-MARKETING AGREEMENT"
Forbes writer Matthew--is a very incompetent Journalist.
1) He says--Jelis was only one study that proved its effectiveness for reducing Cardiac events.
2) He never bothered to read the study--18,000 people studied for 6 years in Japan.
3) He mingles product like Vascepa and Epadel with studies for Lovaza and Fish Oils that contain over 50% of DHA. EPA helps-DHA hurts Lipid profile. Lovaza may lower triglycerides but by raising LDL--most important Lipid profile--it causes problems with Heart.
He wrote an article in 2008--"One Supplement that works"-he was refering to FISH OIL and LOVAZA-based on FAULTY STUDIES.